| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGTC | Common Stock | Sale | -$6.25K | -8.07K | -12.62% | $0.77 | 55.9K | Jul 1, 2022 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of 26,250 shares underlying 35,000 restricted stock units ("RSUs") granted under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan on June 17, 2021. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $0.7700 to $0.7793, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
| F3 | Includes the remaining 8,750 RSUs subject to vesting on December 31, 2022. |